Farflozin 5 mg/10 mg FC tablets
PDF Leaflet Revision Date: 19 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Improves glycaemic control in adults with type 2 diabetes mellitus.
Dosage (summary)
10 mg once daily for adults.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Insulin and insulin secretagogues may increase hypoglycaemia risk.
- Diuretics may increase dehydration risk.
Contraindications
- Type 1 diabetes
- Moderate to severe renal impairment
- Pregnancy and breastfeeding
- History of pancreatitis
Common side effects
- Genital infections
- Urinary tract infections
- Hypoglycaemia
- Dizziness
Counselling Points
- Monitor for signs of dehydration.
- Counsel on genital hygiene to reduce infection risk.
- Assess renal function before and during treatment.
Serious warnings
- Risk of metabolic acidosis and ketoacidosis.
- May cause acute kidney injury.
Important Disclaimer
The Farflozin 5 mg/10 mg FC tablets professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
